Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Susan Valmadre"'
Autor:
Jean Yang, Susan Valmadre, Jaynish S. Shah, Gregory B. Gard, Deborah J. Marsh, Patsy S. Soon, Jayne Maidens
Publikováno v:
Gynecologic Oncology. 148:181-188
© 2017 Elsevier Inc. Objectives The most widely used approach for the clinical management of women with high-grade serous ovarian cancer (HGSOC) is surgery, followed by platinum and taxane based chemotherapy. The degree of macroscopic disease remain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::199a895940275e59075ecee7f4f070f5
https://doi.org/10.1016/j.ygyno.2017.11.005
https://doi.org/10.1016/j.ygyno.2017.11.005
Autor:
Ying Zhu, Alexander J. Cole, Deborah J. Marsh, Jayne Maidens, Gregory B. Gard, Kristie-Ann Dickson, Bing Yu, Anthony J. Gill, Roderick J. Clifton-Bligh, Trisha Dwight, Susan Valmadre
Publikováno v:
Scientific Data
Somatic mutation of the tumor suppressor gene TP53 is reported in at least 50% of human malignancies. Most high-grade serous ovarian cancers (HGSC) have a mutant TP53 allele. Accurate detection of these mutants in heterogeneous tumor tissue is paramo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6881d1715869c52c5043f1512a349ff6
Autor:
Trisha Dwight, Susan Valmadre, Adele Clarkson, Alexander J. Cole, Jayne Maidens, Gregory B. Gard, Deborah J. Marsh, Kristie-Ann Dickson, Ying Zhu, Roderick J. Clifton-Bligh, Anthony J. Gill
Publikováno v:
Scientific Reports
The tumour suppressor p53 is mutated in cancer, including over 96% of high-grade serous ovarian cancer (HGSOC). Mutations cause loss of wild-type p53 function due to either gain of abnormal function of mutant p53 (mutp53), or absent to low mutp53. Ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a920d3425ab3b4508d72711109e144c8
https://doi.org/10.1038/srep26191
https://doi.org/10.1038/srep26191
Publikováno v:
Gynecologic Oncology Case Reports. 2:121-123
Adjuvant intravaginal brachytherapy (IVBT) is an evidenced-based strategy that significantly reduces the long-term rate of post-hysterectomy vaginal mucosal relapse in women with intermediate and high-risk endometrial cancer (EC) (Nout et al., 2010).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d65e51b4ea0bae8d4bd40a773557bc4a
https://doi.org/10.1016/j.gynor.2012.07.001
https://doi.org/10.1016/j.gynor.2012.07.001
Autor:
Peter Russell, Perapong Inthasorn, Jonathan Carter, Christopher Dalrymple, Susan Valmadre, Philip Beale
Publikováno v:
International Journal of Gynecological Cancer. 12:348-353
The aim of this study was to retrospectively analyze the clinical and pathologic data of a series of patients presenting to our unit with uterine malignant mixed Mullerian tumors (MMMT) to attempt to identify prognostic factors and relate them to sur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcf64a4efe19e896505f9dc43f82a1be
https://doi.org/10.1046/j.1525-1438.2002.01117.x
https://doi.org/10.1046/j.1525-1438.2002.01117.x
Publikováno v:
Pathology. 42:483-485
Sir,Simulacra are the bane of the unwary pathologist's life, sometimes with non-trivial clinical or ‘social’ consequences for the patient, from a wrong diagnosis. Epidermolytic hyperkeratosis (EHK)...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6adae0b871d4934251c0145f118af797
https://doi.org/10.3109/00313025.2010.494288
https://doi.org/10.3109/00313025.2010.494288
Publikováno v:
Pathology. 42:95-97
Sir,Endometriosis is a common disorder of women in their reproductive years and pathologists generally have few problems diagnosing characteristic cases. Diagnosis becomes occasionally more challen...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::37584136e9e4593cc570f556bd53e1b3
https://doi.org/10.3109/00313020903434702
https://doi.org/10.3109/00313020903434702
Publikováno v:
Pathology. 34:197-199
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b59467e69f942859647b3b79ba48c58
https://doi.org/10.1016/s0031-3025(16)34507-x
https://doi.org/10.1016/s0031-3025(16)34507-x
Autor:
Alexander J. Cole, Anthony J. Gill, Gregory B. Gard, Roderick J. Clifton-Bligh, Deborah J. Marsh, Adele Clarkson, Kristie-Ann Dickson, Jayne Maidens, Ying Zhu, Trisha Dwight, Susan Valmadre
Publikováno v:
Clinical Cancer Research. 22:B05-B05
Mutations in TP53 have been shown to occur in around 96% of high-grade serous ovarian cancer (HGSOC). Different TP53 mutations can lead to accumulation of mutant p53 in the cell that support gain of function effects, or loss or abrogation of both wil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4d6cea8e13d48ac09ea23e1b63eafb5
https://doi.org/10.1158/1557-3265.ovca15-b05
https://doi.org/10.1158/1557-3265.ovca15-b05
Autor:
R. Houghton, Peter Russell, Paul R. McKenzie, K. Atkinson, Jonathan Carter, Susan Valmadre, Christopher Dalrymple
Publikováno v:
Scopus-Elsevier
Objective The National Health and Medical Research Council (NHMRC) recommends a report of ‘inconclusive - possible high grade epithelial abnormality’, but many laboratories only report ‘inconclusive’ with reference to any possible high grade
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81f525b60c10244d203a74958aea626a
https://pubmed.ncbi.nlm.nih.gov/12403288
https://pubmed.ncbi.nlm.nih.gov/12403288